Three local cos working on antibody drugs for CovidBharat Serums, Intas Pharma and Biological E along with ICMR are working on antibody therapies for Covid-19 in India.
ICMR readies to conduct clinical trials of animal-derived antibodiesAntibodies from animals have been used to control many viral and bacterial infections such as rabies, hepatitis B, vaccine virus, tetanus, ...
DCGI nod to Phase-1 human trials of 'antisera' with potential to treat COVID-19Antisera are blood serum high in antibodies against specific antigens and are injected in humans to help kickstart the immune system to fig...
The road to Covid-19 vaccine: Much progress, some hiccupsThis week, vaccine makers in India and abroad expanded their manufacturing contracts, some got ready for approvals, and others gave a reali...
ICMR, Biological E Ltd develop potential treatment for COVID-19The ICMR in collaboration with a Hyderabad-based biopharmaceutical company has developed "highly purified antisera" prepared by injecting i...
ICMR, Biological E develop purified equine antiserumThe therapy works like plasma therapy. However, the blood plasma is obtained from animals — from horses, in this case — that have recovered...
Covid-19: The frantic search for a cure continuesThough vaccine makers are jumping the usual loops of trial development, regulatory agencies are stepping in to ensure that the companies ar...
Mumbai company working on horse antibodies Covid treatmentThe equine antisera pathway with which the Mumbai-based company is working is already used in treatments against snake bites, rabies and di...
ICMR invites cos to develop its anti-serum against CovidAntiserum is a blood serum that contains antibodies against a virus that can be injected to prevent or treat an infection. Some common exam...
Budget 2011: Finance Bill 2011A BILL to give effect to the financial proposals of the Central Government for the financial year 2011-2012. Be it enacted by Parliament in...